Biorestorative Therapies Inc Stock Ownership - Who owns Biorestorative Therapies?

Insider buying vs selling

Have Biorestorative Therapies Inc insiders been buying or selling?
Dale Broadrick10% Owner2023-09-1510,000$1.66
Lance AlstodtPresident CEO COB2023-09-152,200$1.70
Dale Broadrick10% Owner2023-09-1410,000$1.54
Lance AlstodtPresident CEO COB2023-09-13800$1.53
Dale Broadrick10% Owner2023-09-071,000$1.81
Dale Broadrick10% Owner2023-09-071,000$1.91
Lance AlstodtPresident CEO COB2023-09-062,887$1.96
Francisco SilvaVP of Research and Development2023-08-314,954$2.22
Dale Broadrick10% Owner2023-07-28500$2.89
Dale Broadrick10% Owner2023-07-271,000$2.80

1 of 4

BRTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BRTX insiders and whales buy or sell their stock.

BRTX Shareholders

What type of owners hold Biorestorative Therapies Inc stock?
Westbury Bermuda Ltd1,408.63%65,750,000$103.89MInsider
Trust Westbury408.12%19,049,578$30.10MInsider
Antonio Joel San267.80%12,500,000$19.75MInsider
Janet Montgomery39.73%1,854,428$2.93MInsider
Dale Broadrick13.83%645,545$1.02MInsider
John M. Desmarais10.57%493,398$779.57kInsider
Joseph B. Swiader4.10%191,267$302.20kInsider
Lance Alstodt4.06%189,505$299.42kInsider
Francisco Silva3.79%176,780$279.31kInsider
Vanguard Group Inc2.72%126,956$200.59kInstitution

1 of 3

BRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRTX0.32%99.68%Net BuyingNet Buying
IBIO3.20%96.80%Net SellingNet Selling
FNCH1.28%98.72%Net Selling
TRVN3.95%96.05%Net SellingNet Selling
CYCN9.43%90.57%Net BuyingNet Selling

Biorestorative Therapies Stock Ownership FAQ

Who owns Biorestorative Therapies?

Biorestorative Therapies (NASDAQ: BRTX) is owned by 6.91% institutional shareholders, 2,169.14% Biorestorative Therapies insiders, and 0.00% retail investors. Westbury Bermuda Ltd is the largest individual Biorestorative Therapies shareholder, owning 65.75M shares representing 1,408.63% of the company. Westbury Bermuda Ltd's Biorestorative Therapies shares are currently valued at $117.69M.

If you're new to stock investing, here's how to buy Biorestorative Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.